Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Mesoblast (MESO) over the last 11 years, with Q2 2025 value amounting to $10.8 million.

  • Mesoblast's Other Non-Current Liabilities rose 162.9% to $10.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.8 million, marking a year-over-year increase of 162.9%. This contributed to the annual value of $10.8 million for FY2025, which is 162.9% up from last year.
  • Latest data reveals that Mesoblast reported Other Non-Current Liabilities of $10.8 million as of Q2 2025, which was up 162.9% from $27.6 million recorded in Q4 2024.
  • Over the past 5 years, Mesoblast's Other Non-Current Liabilities peaked at $27.6 million during Q4 2024, and registered a low of $2.2 million during Q2 2022.
  • Its 5-year average for Other Non-Current Liabilities is $16.1 million, with a median of $17.9 million in 2022.
  • In the last 5 years, Mesoblast's Other Non-Current Liabilities plummeted by 3327.05% in 2021 and then soared by 14832.95% in 2023.
  • Over the past 5 years, Mesoblast's Other Non-Current Liabilities (Quarter) stood at $22.3 million in 2021, then decreased by 19.9% to $17.9 million in 2022, then dropped by 4.37% to $17.1 million in 2023, then surged by 61.47% to $27.6 million in 2024, then crashed by 60.85% to $10.8 million in 2025.
  • Its last three reported values are $10.8 million in Q2 2025, $27.6 million for Q4 2024, and $10.6 million during Q2 2024.